0001214659-21-010654.txt : 20211020 0001214659-21-010654.hdr.sgml : 20211020 20211020175903 ACCESSION NUMBER: 0001214659-21-010654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211019 FILED AS OF DATE: 20211020 DATE AS OF CHANGE: 20211020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Yili Kevin CENTRAL INDEX KEY: 0001793506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 211335087 MAIL ADDRESS: STREET 1: C/O VIEWRAY, INC. STREET 2: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-54036.xml PRIMARY DOCUMENT X0306 4 2021-10-19 0001293310 HUMANIGEN, INC HGEN 0001793506 Xie Yili Kevin C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true false false false Stock Option (Right to Buy) 6.56 2021-10-19 4 A false 42866 0 A 2022-03-31 2031-10-18 Common Stock 42866 42866 D The option vests in 12 ratable quarterly installments commencing March 31, 2022. /s/ Timothy E. Morris, Attorney-in-Fact 2021-10-20